Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-10 Purchase | 2025-02-27 6:42 pm | Oruka Therapeutics Inc. | ORKA | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 122,882 | $11.45 | $1,407,368 | 4,148,428 (Indirect) | View |
| 2024-08-16 Purchase | 2024-08-20 2:23 pm | ARCA biopharma Inc. | ABIO | JANUS HENDERSON GROUP PLC Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner | 5,818 | $2.9334 | $17,067 | 2,117,213 (Indirect) | View |
| 2024-07-24 Purchase | 2024-07-26 10:50 am | ARCA biopharma Inc. | ABIO | JANUS HENDERSON GROUP PLC Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner | 220,083 | $3.1768 | $699,165 | 2,111,395 (Indirect) | View |
| 2024-07-03 Purchase | 2024-07-12 7:38 pm | ARCA biopharma Inc. | ABIO | JANUS HENDERSON GROUP PLC Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner | 408,777 | $3.4917 | $1,427,345 | 1,891,312 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-02-27 6:42 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner | 0 | $0 | 4,550,089 (Indirect) | View |
| 2025-01-22 Option Award | 2025-01-24 4:44 pm | N/A 2035-01-21 | Oruka Therapeutics Inc. | ORKA | Agarwal Arjun SVP, Finance | 120,000 | $0 | 120,000 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:43 pm | N/A 2035-01-21 | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 162,500 | $0 | 162,500 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:42 pm | N/A 2035-01-21 | Oruka Therapeutics Inc. | ORKA | Quinlan Paul T General Counsel | 162,500 | $0 | 162,500 (Direct) | View |
| 2025-01-22 Option Award | 2025-01-24 4:41 pm | N/A 2035-01-21 | Oruka Therapeutics Inc. | ORKA | Klein Lawrence Otto Chief Executive Officer | 230,000 | $0 | 230,000 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-21 6:30 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 160,160 | $0 | 3,371,922 (Indirect) | View |
| 2024-09-11 Option Award | 2024-09-13 4:55 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 275,000 | $23 | 3,212,082 (Indirect) | View |
| 2024-09-11 Option Award | 2024-09-13 4:55 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 160 | $23,000 | 3,212,082 (Indirect) | View |
Ownership | 2024-09-06 5:07 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 19,662,752 (Indirect) | View |
Ownership | 2024-09-06 5:07 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Turtle Cameron Director | 0 | $0 | 94,281 (Indirect) | View |
Ownership | 2024-09-06 5:06 pm | N/A 2034-03-22 | Oruka Therapeutics Inc. | ORKA | Kulkarni Samarth Director | 0 | $0 | 199,992 (Direct) | View |
Ownership | 2024-09-06 5:05 pm | N/A 2024-05-06 | Oruka Therapeutics Inc. | ORKA | Dambkowski Carl Director | 0 | $0 | 94,282 (Direct) | View |
Ownership | 2024-09-06 5:04 pm | N/A 2034-05-06 | Oruka Therapeutics Inc. | ORKA | BALL KRISTINE M Director | 0 | $0 | 94,282 (Direct) | View |
Ownership | 2024-09-06 5:03 pm | N/A 2034-05-06 | Oruka Therapeutics Inc. | ORKA | Quinlan Paul T General Counsel and Secretary | 0 | $0 | 328,559 (Direct) | View |
Ownership | 2024-09-06 5:02 pm | N/A 2034-05-06 | Oruka Therapeutics Inc. | ORKA | Goncalves Joana Chief Medical Officer | 0 | $0 | 428,555 (Direct) | View |
Ownership | 2024-09-06 5:01 pm | N/A 2034-03-22 | Oruka Therapeutics Inc. | ORKA | Agarwal Arjun SVP, Finance and Treasurer | 0 | $0 | 214,277 (Direct) | View |
Ownership | 2024-09-06 5:00 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Klein Lawrence Otto President and CEO | 0 | $0 | 2,480,851 (Direct) | View |
| 2024-08-29 Other | 2024-08-30 5:57 pm | N/A 2034-01-30 | ARCA biopharma Inc. | ABIO | Ma-Weaver Jacob See footnote 1 | 24,000 | $0 | 0 (Direct) | View |
Ownership | 2024-07-12 7:10 pm | N/A N/A | ARCA biopharma Inc. | ABIO | JANUS HENDERSON GROUP PLC Janus Henderson Biotech Innovation Master Fund Ltd 10% Owner | 0 | $0 | 1,482,535 (Indirect) | View |
| 2024-01-30 Option Award | 2024-01-31 6:39 pm | N/A 2034-01-30 | ARCA biopharma Inc. | ABIO | Ma-Weaver Jacob See footnote 1 10% Owner | 6,000 | $0 | 6,000 (Direct) | View |
| 2024-01-30 Option Award | 2024-01-31 4:25 pm | N/A 2034-01-30 | ARCA biopharma Inc. | ABIO | Hove Anders D Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2024-01-30 Option Award | 2024-01-31 4:25 pm | N/A 2034-01-30 | ARCA biopharma Inc. | ABIO | MITCHELL DANIEL J Director | 6,000 | $0 | 6,611 (Direct) | View |
| 2024-01-30 Option Award | 2024-01-31 4:25 pm | N/A 2034-01-30 | ARCA biopharma Inc. | ABIO | Flynn James P Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2024-01-30 Option Award | 2024-01-31 4:25 pm | N/A 2034-01-30 | ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board | 6,000 | $0 | 56,000 (Direct) | View |
| 2024-01-30 Option Award | 2024-01-31 4:25 pm | N/A 2034-01-30 | ARCA biopharma Inc. | ABIO | Grais Linda Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2024-01-30 Option Award | 2024-01-31 4:25 pm | N/A 2034-01-30 | ARCA biopharma Inc. | ABIO | Woosley Raymond L. Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-12-16 Exercise | 2022-12-19 5:33 pm | N/A N/A | ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner | 1,420,000 | $2.5 | 4,048,452 (Direct) | View |
| 2022-12-16 Expired | 2022-12-19 5:33 pm | 2022-12-16 2022-12-16 | ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner | 300 | $0 | 4,048,452 (Direct) | View |
| 2022-12-16 Exercise | 2022-12-19 5:33 pm | 2022-12-16 2022-12-16 | ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner | 14,200 | $0 | 4,048,452 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 5:33 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | Funicular Funds LP Ma-Weaver Jacob See Footnote 1 10% Owner | 6,000 | $0 | 4,048,452 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:30 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | Woosley Raymond L. Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:24 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | MITCHELL DANIEL J Director | 6,000 | $0 | 6,611 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:24 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | Grais Linda Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:23 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | Hove Anders D Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:20 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board | 6,000 | $0 | 56,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:19 pm | N/A 2032-12-15 | ARCA biopharma Inc. | ABIO | Flynn James P Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-12-08 Option Award | 2022-12-09 4:30 pm | N/A N/A | ARCA biopharma Inc. | ABIO | Keuer Thomas A Chief Operating Officer | 40,000 | $0 | 40,730 (Direct) | View |
| 2022-12-08 Option Award | 2022-12-09 4:30 pm | N/A N/A | ARCA biopharma Inc. | ABIO | Dekker C. Jeffrey Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-07-01 Other | 2022-07-08 7:17 pm | 2022-12-16 2022-12-16 | ARCA biopharma Inc. | ABIO | Funicular Funds LP See Footnote 1 10% Owner | 2,609,452 | $0 | 11,771,808 (Indirect) | View |